Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
While both medications are proven to be effective, tirzepatide has a clear advantage over semaglutide
Branded tirzepatide (Zepbound) FDA-approved tirzepatide indicated for chronic weight management
Aiming for a lower HbA 1c level than this may have value if it can be achieved safely without significant hypoglycaemia or other adverse treatment effects
Abdomen (avoid the area around your belly button)
Pfizers $10B bet implies the company believes these eventualities are manageable or that the benefits (market share, IP, platform) outweigh risks
The efficacy and safety of the combination therapy with GLP-1 receptor agonists and SGLT-2 inhibitors in type 2 diabetes mellitus: A systematic review and meta-analysis
US$ 27.92
US$ 28.29
US$ 23.45
US$ 28.63
US$ 27.94
US$ 26.85
